Latest Cornell dot features a new cancer weapon: antibodies
(PHYSorg.com Nanotechnology)

Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety.